Dihydropyridine derivatives

Nimodipine

Approved 2 May 2007OralCapsule

The FDA lists this product in 8 strengths and forms.

Official labelAsk Osler about it

Composition

Active ingredients: NIMODIPINE 30MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA077811.

Open Drugs@FDA

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Nimodipine
Drug class: Dihydropyridine derivatives
Group: Calcium channel blockers
Route: Oral
Dosage form: Capsule
Applicant: Heritage
Status: Prescription
FDA approval: 2 May 2007
Application: ANDA077811-001
RxCUI: 7426

Guidelines

FDA 2016

Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazideamlodipine besylate · Tablet

CelecoxibCapsule

TelmisartanTablet

Amlodipine Besylate and Atorvastatin Calciumamlodipine besylate · Tablet

Amlodipine Besylate and Valsartanamlodipine besylate · Tablet

Amlodipine and Olmesartan Medoxomilamlodipine besylate · Tablet

Trandolapril and Verapamil Hydrochloridetrandolapril · Tablet, extended release

Diltiazem HydrochlorideTablet, extended release

Twynstaamlodipine besylate · Tablet

RamiprilTablet

Cleviprexclevidipine · Emulsion

Nicardipine Hydrochloride in 0.9% Sodium Chloridenicardipine hydrochloride · Injectable

Nicardipine HydrochlorideInjectable

Amlodipine Besylate and Benazepril Hydrochlorideamlodipine besylate · Capsule

TrandolaprilTablet

Amlodipine Maleate; Benazepril Hydrochlorideamlodipine maleate · Capsule